Hjem
Forskningsgruppe for paraneoplasi

Varselmelding

There has not been added a translated version of this content. You can either try searching or go to the "area" home page to see if you can find the information there

2. PCD: Neuroprotective drugs

Autoantibody uptake: from Fc receptors to calcium signaling?

2

Hovedinnhold

To this date, there is no cure for the progressive neuronal loss seen in PCD patients. Even though removal of the tumor prevents further neuronal damage, it does not reverse the existing neurodegeneration and leaves the patients in severe disabled state, which is a burden both economically and socially. Our objective is to develop ex-vivo and in-vivo PCD models where we can pharmacologically target single molecules which are negatively affected by the CDR antibody binding. Investigating the drug effects not only on a cellular level but also at the entire CNS/body level will be the first milestone towards clinical trials regarding PCD related neuroprotective therapy.

Additional details: